ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.170
+0.090 (4.33%)
Mar 17, 2026, 4:00 PM EDT - Market closed
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $285.59 million as of March 17, 2026. Its market cap has increased by 425.70% in one year.
Market Cap
285.59M
Enterprise Value
255.57M
1-Year Change
425.70%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $285.59M, a decrease of -72.96%. That is a compound annual growth rate of -20.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 285.59M | 366.14% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 305.88M |
| Cabaletta Bio | 298.42M |
| Foghorn Therapeutics | 297.02M |
| Palisade Bio | 296.52M |
| Protara Therapeutics | 294.76M |
| Camp4 Therapeutics | 288.15M |
| Avalo Therapeutics | 278.90M |
| Abeona Therapeutics | 271.55M |